SANNSanthera Pharmaceuticals Holding AG
16.64CHF+0.73%Mkt Cap: 289.54M $P/E:

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Euro…

Key Statistics

Company
Market Cap289.54M $
Enterprise Value282.78M $
Revenue (TTM)88.09M $
Gross Profit17.32M $
Net Income (TTM)-56.19M $
Revenue/Share6.769 USD
Last Price16.64 CHF
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees93
CountryCH
SectorHealthcare
IndustryBiotechnology
ISINCH0027148649
Valuation
P/E (Trailing)
P/E (Forward)95.53
PEG
EV/EBITDA-7.62
EV/Revenue3.21
P/S3.21
P/B-18.41
EPS (TTM)-3.78
EPS (Forward)0.17
52W Range
9.38077% of range18.84
52W High18.84 CHF
52W Low9.380 CHF
Profitability
Gross Margin19.66%
Oper. Margin-4.08%
EBITDA Margin-42.15%
Profit Margin-63.79%
ROE416.69%
ROA-33.25%
Growth
Revenue Growth112.70%
Earnings Growth
Cash Flow & Leverage
Operating CF-39.68M $
CapEx (TTM)59.35K $
FCF Margin-46.17%
FCF Yield-14.05%
Net Debt30.25M $
Net Debt/EBITDA-0.81
Balance Sheet
Debt/Equity-4.14
Current Ratio1.29
Quick Ratio0.78
Book Value/Sh-0.8820 CHF
Cash/Share1.675 CHF
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 CHF
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay DateSep 8, 2022
Splits
Last Split1:10
Split DateJul 3, 2023
Analyst Consensus
Rating
Target (Mean)27.50 CHF
Upside (mean)+65.3%
Target Range25.00 CHF30.00 CHF
CHF25.00+65.3% to meanCHF30.00
# Analysts2
Ownership
Shares Out.15.25M
Float11.27M
Insiders14.57%
Institutions11.10%
Technical
SMA 5015.40 (+8.0%)
SMA 20014.76 (+12.8%)
Beta-0.28
S&P 52W Chg18.16%
Avg Vol (30d)82.48K
Avg Vol (10d)96.11K
Technical Indicators
RSI (14)60.3
MACD0.3425
MACD Signal0.1236
MACD Hist.+0.2189
BB Upper17.12 CHF
BB Middle15.31 CHF
BB Lower13.50 CHF
BB Width23.63%
ATR (14)0.7299 CHF
Vol Ratio (20d)1.87x